| GA20053-1mg |
|
1678415-32-1 |
(Cys²⁶)-Amyloid β-Protein (1-40)
|
0 |
C194H295N53O57S2 |
|
|
|
| GA20053-005mg |
|
1678415-32-1 |
(Cys²⁶)-Amyloid β-Protein (1-40)
|
0 |
C194H295N53O57S2 |
|
|
|
| GA20052-005mg |
|
1802087-75-7 |
(Cys²⁶)-Amyloid β-Protein (1-40) (Dimer)
|
0 |
C388H588N106O114S4 |
|
|
|
| GA20052-001mg |
|
1802087-75-7 |
(Cys²⁶)-Amyloid β-Protein (1-40) (Dimer)
|
0 |
C388H588N106O114S4 |
|
|
|
| GA20051-1mg |
|
111863-73-1 |
(Cys¹⁸)-Atrial Natriuretic Factor (4-18) amide (mouse, rabbit, rat)
|
0 |
C64H107N25O19S2 |
|
|
|
| GA20051-005mg |
|
111863-73-1 |
(Cys¹⁸)-Atrial Natriuretic Factor (4-18) amide (mouse, rabbit, rat)
|
0 |
C64H107N25O19S2 |
|
|
|
| GA20050-1mg |
|
208266-35-7 |
(Cys⁰)-Amyloid β-Protein (1-40)
|
0 |
C197H300N54O59S2 |
|
|
|
| GA20050-005mg |
|
208266-35-7 |
(Cys⁰)-Amyloid β-Protein (1-40)
|
0 |
C197H300N54O59S2 |
|
|
|
| GA20049-1mg |
|
2022974-96-3 |
(Cys(Acm)⁶·¹²)-Orexin A (human, mouse, rat)
|
0 |
C158H255N49O46S4 |
|
|
|
| GA20049-005mg |
|
2022974-96-3 |
(Cys(Acm)⁶·¹²)-Orexin A (human, mouse, rat)
|
0 |
C158H255N49O46S4 |
|
|
|
| GA20048-100g |
|
10389-65-8 |
|
0 |
C16H28N2O8S2 |
|
|
|
| GA20048-25g |
|
10389-65-8 |
|
0 |
C16H28N2O8S2 |
|
|
|
| GA20048-5g |
|
10389-65-8 |
|
0 |
C16H28N2O8S2 |
|
|
|
| GA20047-1mg |
|
79804-72-1 |
(Asp⁷⁶)-pTH (39-84) (human)
|
0 |
C211H356N66O73 |
|
|
|
| GA20047-005mg |
|
79804-72-1 |
(Asp⁷⁶)-pTH (39-84) (human)
|
0 |
C211H356N66O73 |
|
|
|
| GA20046-1mg |
|
89899-56-9 |
|
0 |
C405H668N122O126S3 |
|
|
|
| GA20046-005mg |
|
89899-56-9 |
|
0 |
C405H668N122O126S3 |
|
|
|
| GA20045-1mg |
|
1875128-79-2 |
(Asp³⁷)-Amyloid β-Protein (1-42)
|
0 |
C205H313N55O62S |
|
|
|
| GA20045-005mg |
|
1875128-79-2 |
(Asp³⁷)-Amyloid β-Protein (1-42)
|
0 |
C205H313N55O62S |
|
|
|
| GA20044-1mg |
|
1037751-81-7 |
(Asp²⁸)-Glucagon (1-29) (human, rat, porcine)
|
0 |
C153H224N42O50S |
|
|
|
